East India Pharmaceutical Works Limited
₹ 79▲0.00%(0.00)
About the company
East India Pharmaceutical Works Limited (EIPWL) is one of India's oldest and most respected pharmaceutical companies, with a legacy that dates back to 1936. Headquartered in Kolkata, West Bengal, the company has been serving the healthcare industry for more than eight decades by developing, manufacturing, and marketing a wide range of pharmaceutical and healthcare products. Its long-standing presence reflects a commitment to quality, reliability, and continuous innovation in meeting the evolving healthcare needs of patients and medical professionals.
Fundamentals
Valuation
- 52 week high
- —
- 52 week low
- —
- P/B ratio
- 0.78
- Debt to equity
- 0.92
- ROE (%)
- 3.47%
- Book value
- ₹101.38
- Face value
- ₹10
- Valuation
- —
Registry
- ISIN number
- INE254X01017
Figures in cr ·
Financials
| P&L Statement | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 234 | 250 | 272 |
| EBITDA | 10 | 12.4 | 13 |
| OPM | 4.27 | 4.96 | 4.78 |
| PBT | 2.4 | 4.5 | 4 |
| PAT | 1.7 | 3.8 | 2 |
| EPS | 2.55 | 5.7 | 3 |
Shareholding Pattern
Leadership
| Name | Role | Experience | |
|---|---|---|---|
| D. Duttagupta | Managing Director | 30+ yrs experience | — |
| Mrs. S. Mukherjee | Director | 25+ yrs experience | — |
| S. Ray | CFO | 30+ yrs experience | — |
Frequently asked questions
Common questions on East India Pharmaceutical Works Limited—tap a row to read the answer.
Q.1What are East India Pharmaceutical Works Limited unlisted shares?
East India Pharmaceutical Works Limited unlisted shares are equity shares of the company that are not traded on any recognized stock exchange. These shares are bought and sold through private transactions in the unlisted market, offering investors an opportunity to invest in the company before any potential public listing.
Q.2How can I buy East India Pharmaceutical Works Limited unlisted shares?
You can purchase East India Pharmaceutical Works Limited unlisted shares through registered brokers or intermediaries that specialize in unlisted share transactions. Once the buyer and seller agree on the price and quantity, the necessary documentation is completed, and the shares are transferred to the buyer's Demat account.
Q.3Is it legal to invest in East India Pharmaceutical Works Limited unlisted shares?
Yes. Buying and selling East India Pharmaceutical Works Limited unlisted shares is legal in India when the transaction follows applicable laws and regulatory guidelines. Investors should ensure that the shares are transferred through valid procedures and credited to their Demat account.
Q.4Why do investors consider East India Pharmaceutical Works Limited unlisted shares?
Many investors consider East India Pharmaceutical Works Limited unlisted shares because of the company's long operating history, established presence in the pharmaceutical industry, and potential for future business growth. However, investment decisions should always be based on careful analysis of the company's financial performance, valuation, and long-term prospects.
Q.5What should I evaluate before investing in East India Pharmaceutical Works Limited unlisted shares?
Before investing, review the company's financial statements, revenue and profit trends, product portfolio, management team, manufacturing capabilities, debt position, competitive strengths, and future growth strategy. Assessing these factors can help you determine whether the investment aligns with your financial goals.
Q.6Can I sell East India Pharmaceutical Works Limited unlisted shares whenever I want?
Yes, provided there is a willing buyer. Since unlisted shares are traded privately rather than on stock exchanges, the time required to complete the transaction depends on buyer availability, mutually agreed pricing, and the completion of transfer formalities.
Trending shares
High-demand unlisted opportunities currently available for trade.
From the blog
Notes on unlisted markets, execution hygiene, and how we think about risk—no hype, no ticker spam.

APTUS PHARMA IPO
Aptus Pharma Limited rolled out its 100% book-built BSE SME public offering worth ₹13.02 Crore. Review crucial parameters for retail investors, featuring the ₹65–₹70 price band, working capital allocations, and an evaluation of its contract-manufacturing partner model.

NEPHROPLUS (NEPHROCARE HEALTH SERVICES) IPO
Explore the Neochem Bio IPO, including issue details, business strengths, risks, and investment analysis.

APOLLO TECHNO INDUSTRIES IPO
Apollo Techno Industries Limited has announced its public offering details. Explore the essential investment parameters for retail and institutional bidders, highlighting the fixed price band, lot structure, key market deadlines, and an overview of its industrial manufacturing footprint.

NEOCHEM BIO IPO
Explore the Neochem Bio IPO, including issue details, business strengths, risks, and investment analysis.

ANONDITA MEDICARE IPO
Anondita Medicare Limited rolled out its 100% book-built SME public offering worth ₹69.50 Crore on the NSE SME platform. Dig into the critical parameters for investors, highlighting the ₹137–₹145 price band, key working capital objectives, and an analysis of its flagship brand 'COBRA' within the growing sexual wellness market.

NEPTUNE LOGITEK IPO
Explore the Neptune Logitek IPO, including issue details, business strengths, risks, and investment analysis.
